TickerFacts.

Quest Diagnostics Inc (DGX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.36B
Year ended 2025-12-31
$1.35B
Trailing 12 months to 2026-06-30
+1.1%
3-year compound annual growth
-3.1%
5-year compound annual growth
$1.83B2007-12-31: $707.82M2008-12-31: $850.37M2009-12-31: $830.49M2010-12-31: $912.65M2011-12-31: $734.00M2012-12-31: $1.00B2013-12-31: $421.00M2014-12-31: $636.00M2015-12-31: $558.00M2016-12-31: $823.00M2017-12-31: $923.00M2018-12-31: $817.00M2019-12-31: $843.00M2020-12-31: $1.59B2021-12-31: $1.83B2022-12-31: $1.31B2023-12-31: $864.00M2024-12-31: $909.00M2025-12-31: $1.36B$1.36B
2007-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$1.36B+49.5%2026-02-26, From 2025-01-01
2024-12-31$909.00M+5.2%2026-02-26, From 2024-01-01
2023-12-31$864.00M-34.2%2026-02-26, From 2023-01-01
2022-12-31$1.31B-28.2%2025-02-20, From 2022-01-01
2021-12-31$1.83B+15.3%2024-02-22, From 2021-01-01
2020-12-31$1.59B+88.3%2023-02-21, From 2020-01-01
2019-12-31$843.00M+3.2%2022-02-28, From 2019-01-01
2018-12-31$817.00M-11.5%2021-02-22, From 2018-01-01
2017-12-31$923.00M+12.2%2020-02-20, From 2017-01-01
2016-12-31$823.00Mn/c2019-02-21, From 2016-01-01
2015-12-31$558.00M-12.3%2018-02-23, From 2015-01-01
2014-12-31$636.00M+51.1%2017-02-22, From 2014-01-01
2013-12-31$421.00M-58.1%2016-02-26, From 2013-01-01
2012-12-31$1.00B+36.9%2015-02-24, From 2012-01-01
2011-12-31$734.00M-19.6%2014-02-18, From 2011-01-01
2010-12-31$912.65M+9.9%2013-02-27, From 2010-01-01
2009-12-31$830.49M-2.3%2012-02-16, From 2009-01-01
2008-12-31$850.37M+20.1%2011-02-16, From 2008-01-01
2007-12-31$707.82Mn/a2010-02-17, From 2007-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$1.36B+49.5%
Labcorp Holdings Inc. (LH)2025-12-31$1.21B+10.0%
Fortrea Holdings Inc. (FTRE)2025-12-31$88.30M-62.8%
Natera, Inc. (NTRA)2025-12-31$109.11M+57.6%
Guardant Health, Inc. (GH)2025-12-31-$233.07Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$66.89Mn/m
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m

Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗